Clinical Trials Logo

Clinical Trial Summary

The rationale of the present study was to evaluate the efficacy of DAT in children and adolescents with FASD in relation to its effects on social skills, internalized and externalized symptomatology and on severity of FASD symptoms. This objective was accomplished through a randomized controlled pilot study of DAT for children and adolescents with FASD.


Clinical Trial Description

The rationale of this study was to evaluate the efficacy of Dog Assisted Therapy in children and adolescents with FASD. The investigators conducted a randomized, rater-blinded, controlled pilot trial in a cohort of 33 children and adolescents with FASD. Participants were randomly assigned either to DAT group (n=17) or Treatment as Usual (TAU control group) (n=16). The investigators evaluated changes on social skills, internalized and externalized symptomatology and on severity of FASD symptoms at pre-treatment and post-treatment. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04038164
Study type Interventional
Source Hospital Universitari Vall d'Hebron Research Institute
Contact
Status Completed
Phase N/A
Start date April 2, 2018
Completion date April 2, 2019

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04664790 - Hyperbaric Oxygen Therapy Compared to Cognitive Training in FASD N/A